Industry Research Reports
Global Hepatocyte Growth Factor Market Research Report 2025
Industry: Pharma & Healthcare
Published Date: 2025-08-13
Pages: 82 Pages
Report ld: 3469991
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Hepatocyte Growth Factor Market Size(US$)
CAGR 2025-2031
28.0%
Market Size,2031
USD 426
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 97 million
Market Forecast in 2031(Value)
US$ 426 million
CAGR
28.0%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Hepatocyte Growth Factor was valued at US$ 75.8 million in the year 2024 and is projected to reach a revised size of US$ 426 million by 2031, growing at a CAGR of 28.0% during the forecast period.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Hepatocyte Growth Factor competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Hepatocyte growth factor (HGF) (or scatter factor (SF) is a paracrine cellular growth, motility and morphogenic factor. It is secreted by mesenchymal cells and targets and acts primarily upon epithelial cells and endothelial cells, but also acts on haemopoietic progenitor cells and T cells. It has been shown to have a major role in embryonic organ development, specifically in myogenesis, in adult organ regeneration, and in wound healing.
Current drug development targeting the HGF pathway is bifurcated into neuroregeneration and oncology tracks, with clinical pipelines focused on indications such as diabetic neuropathy, ALS, spinal cord injury, stroke, and various solid tumors including NSCLC and gastric cancer. Globally, companies like Helixmith, AnGes MG, and Kringle Pharma are advancing gene therapies and recombinant proteins for neurological indications. Athira Pharma and AVEO are developing small molecules and antibodies targeting the HGF/c-Met axis, while Exelixis and Molecular Partners pursue broader oncology strategies via multi-target approaches. Beijing Northland represents China’s early-stage involvement in this area. The landscape is marked by diversified modalities and parallel development paths, with several assets reaching late-stage trials or conditional approvals, indicating strong commercialization potential in regenerative medicine and rare diseases.
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Hepatocyte Growth Factor, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hepatocyte Growth Factor.
The Hepatocyte Growth Factor market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Hepatocyte Growth Factor market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hepatocyte Growth Factor manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Helixsmith
Exelixis
AnGes MG
Athira Pharma
AVEO Pharmaceuticals
Molecular Partners
Kringle Pharma
Beijing Northland
Segment by Type
Phase III (Ongoing)
Phase II (Approved)
Phase II (Ongoing)
Phase 1
Preclinical
Approved / Marketed
Segment by Application
Oncology
Cardiovascular
Central Nervous System
Hematological Disorders
Others
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Hepatocyte Growth Factor manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Hepatocyte Growth Factor in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Hepatocyte Growth Factor Market Overview
1.1 Product Definition
1.2 Hepatocyte Growth Factor by Type
1.2.1 Global Hepatocyte Growth Factor Market Value Comparison by Type (2024 VS 2031)
1.2.2 Phase III (Ongoing)
1.2.3 Phase II (Approved)
1.2.4 Phase II (Ongoing)
1.2.5 Phase 1
1.2.6 Preclinical
1.2.7 Approved / Marketed
1.3 Hepatocyte Growth Factor by Application
1.3.1 Global Hepatocyte Growth Factor Market Value by Application (2024 VS 2031)
1.3.2 Oncology
1.3.3 Cardiovascular
1.3.4 Central Nervous System
1.3.5 Hematological Disorders
1.3.6 Others
1.4 Global Hepatocyte Growth Factor Market Size Estimates and Forecasts
1.4.1 Global Hepatocyte Growth Factor Revenue 2020-2031
1.4.2 Global Hepatocyte Growth Factor Sales 2020-2031
1.4.3 Global Hepatocyte Growth Factor Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Hepatocyte Growth Factor Market Competition by Manufacturers
2.1 Global Hepatocyte Growth Factor Sales Market Share by Manufacturers (2020-2025)
2.2 Global Hepatocyte Growth Factor Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Hepatocyte Growth Factor Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Hepatocyte Growth Factor, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Hepatocyte Growth Factor, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Hepatocyte Growth Factor, Product Type & Application
2.7 Global Key Manufacturers of Hepatocyte Growth Factor, Date of Enter into This Industry
2.8 Global Hepatocyte Growth Factor Market Competitive Situation and Trends
2.8.1 Global Hepatocyte Growth Factor Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Hepatocyte Growth Factor Players Market Share by Revenue
2.8.3 Global Hepatocyte Growth Factor Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Hepatocyte Growth Factor Market Scenario by Region
3.1 Global Hepatocyte Growth Factor Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Hepatocyte Growth Factor Sales by Region: 2020-2031
3.2.1 Global Hepatocyte Growth Factor Sales by Region: 2020-2025
3.2.2 Global Hepatocyte Growth Factor Sales by Region: 2026-2031
3.3 Global Hepatocyte Growth Factor Revenue by Region: 2020-2031
3.3.1 Global Hepatocyte Growth Factor Revenue by Region: 2020-2025
3.3.2 Global Hepatocyte Growth Factor Revenue by Region: 2026-2031
3.4 North America Hepatocyte Growth Factor Market Facts & Figures by Country
3.4.1 North America Hepatocyte Growth Factor Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Hepatocyte Growth Factor Sales by Country (2020-2031)
3.4.3 North America Hepatocyte Growth Factor Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Hepatocyte Growth Factor Market Facts & Figures by Country
3.5.1 Europe Hepatocyte Growth Factor Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Hepatocyte Growth Factor Sales by Country (2020-2031)
3.5.3 Europe Hepatocyte Growth Factor Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Hepatocyte Growth Factor Market Facts & Figures by Region
3.6.1 Asia Pacific Hepatocyte Growth Factor Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Hepatocyte Growth Factor Sales by Region (2020-2031)
3.6.3 Asia Pacific Hepatocyte Growth Factor Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Hepatocyte Growth Factor Market Facts & Figures by Country
3.7.1 Latin America Hepatocyte Growth Factor Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Hepatocyte Growth Factor Sales by Country (2020-2031)
3.7.3 Latin America Hepatocyte Growth Factor Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Hepatocyte Growth Factor Market Facts & Figures by Country
3.8.1 Middle East and Africa Hepatocyte Growth Factor Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Hepatocyte Growth Factor Sales by Country (2020-2031)
3.8.3 Middle East and Africa Hepatocyte Growth Factor Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Hepatocyte Growth Factor Sales by Type (2020-2031)
4.1.1 Global Hepatocyte Growth Factor Sales by Type (2020-2025)
4.1.2 Global Hepatocyte Growth Factor Sales by Type (2026-2031)
4.1.3 Global Hepatocyte Growth Factor Sales Market Share by Type (2020-2031)
4.2 Global Hepatocyte Growth Factor Revenue by Type (2020-2031)
4.2.1 Global Hepatocyte Growth Factor Revenue by Type (2020-2025)
4.2.2 Global Hepatocyte Growth Factor Revenue by Type (2026-2031)
4.2.3 Global Hepatocyte Growth Factor Revenue Market Share by Type (2020-2031)
4.3 Global Hepatocyte Growth Factor Price by Type (2020-2031)
5 Segment by Application
5.1 Global Hepatocyte Growth Factor Sales by Application (2020-2031)
5.1.1 Global Hepatocyte Growth Factor Sales by Application (2020-2025)
5.1.2 Global Hepatocyte Growth Factor Sales by Application (2026-2031)
5.1.3 Global Hepatocyte Growth Factor Sales Market Share by Application (2020-2031)
5.2 Global Hepatocyte Growth Factor Revenue by Application (2020-2031)
5.2.1 Global Hepatocyte Growth Factor Revenue by Application (2020-2025)
5.2.2 Global Hepatocyte Growth Factor Revenue by Application (2026-2031)
5.2.3 Global Hepatocyte Growth Factor Revenue Market Share by Application (2020-2031)
5.3 Global Hepatocyte Growth Factor Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Helixsmith
6.1.1 Helixsmith Company Information
6.1.2 Helixsmith Description and Business Overview
6.1.3 Helixsmith Hepatocyte Growth Factor Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Helixsmith Hepatocyte Growth Factor Product Portfolio
6.1.5 Helixsmith Recent Developments/Updates
6.2 Exelixis
6.2.1 Exelixis Company Information
6.2.2 Exelixis Description and Business Overview
6.2.3 Exelixis Hepatocyte Growth Factor Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Exelixis Hepatocyte Growth Factor Product Portfolio
6.2.5 Exelixis Recent Developments/Updates
6.3 AnGes MG
6.3.1 AnGes MG Company Information
6.3.2 AnGes MG Description and Business Overview
6.3.3 AnGes MG Hepatocyte Growth Factor Sales, Revenue and Gross Margin (2020-2025)
6.3.4 AnGes MG Hepatocyte Growth Factor Product Portfolio
6.3.5 AnGes MG Recent Developments/Updates
6.4 Athira Pharma
6.4.1 Athira Pharma Company Information
6.4.2 Athira Pharma Description and Business Overview
6.4.3 Athira Pharma Hepatocyte Growth Factor Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Athira Pharma Hepatocyte Growth Factor Product Portfolio
6.4.5 Athira Pharma Recent Developments/Updates
6.5 AVEO Pharmaceuticals
6.5.1 AVEO Pharmaceuticals Company Information
6.5.2 AVEO Pharmaceuticals Description and Business Overview
6.5.3 AVEO Pharmaceuticals Hepatocyte Growth Factor Sales, Revenue and Gross Margin (2020-2025)
6.5.4 AVEO Pharmaceuticals Hepatocyte Growth Factor Product Portfolio
6.5.5 AVEO Pharmaceuticals Recent Developments/Updates
6.6 Molecular Partners
6.6.1 Molecular Partners Company Information
6.6.2 Molecular Partners Description and Business Overview
6.6.3 Molecular Partners Hepatocyte Growth Factor Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Molecular Partners Hepatocyte Growth Factor Product Portfolio
6.6.5 Molecular Partners Recent Developments/Updates
6.7 Kringle Pharma
6.7.1 Kringle Pharma Company Information
6.7.2 Kringle Pharma Description and Business Overview
6.7.3 Kringle Pharma Hepatocyte Growth Factor Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Kringle Pharma Hepatocyte Growth Factor Product Portfolio
6.7.5 Kringle Pharma Recent Developments/Updates
6.8 Beijing Northland
6.8.1 Beijing Northland Company Information
6.8.2 Beijing Northland Description and Business Overview
6.8.3 Beijing Northland Hepatocyte Growth Factor Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Beijing Northland Hepatocyte Growth Factor Product Portfolio
6.8.5 Beijing Northland Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Hepatocyte Growth Factor Industry Chain Analysis
7.2 Hepatocyte Growth Factor Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Hepatocyte Growth Factor Production Mode & Process Analysis
7.4 Hepatocyte Growth Factor Sales and Marketing
7.4.1 Hepatocyte Growth Factor Sales Channels
7.4.2 Hepatocyte Growth Factor Distributors
7.5 Hepatocyte Growth Factor Customer Analysis
8 Hepatocyte Growth Factor Market Dynamics
8.1 Hepatocyte Growth Factor Industry Trends
8.2 Hepatocyte Growth Factor Market Drivers
8.3 Hepatocyte Growth Factor Market Challenges
8.4 Hepatocyte Growth Factor Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Hepatocyte Growth Factor Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Hepatocyte Growth Factor Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Hepatocyte Growth Factor Market Competitive Situation by Manufacturers in 2024
Table 4. Global Hepatocyte Growth Factor Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Hepatocyte Growth Factor Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Hepatocyte Growth Factor Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Hepatocyte Growth Factor Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Hepatocyte Growth Factor Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Hepatocyte Growth Factor, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Hepatocyte Growth Factor, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Hepatocyte Growth Factor, Product Type & Application
Table 12. Global Key Manufacturers of Hepatocyte Growth Factor, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Hepatocyte Growth Factor by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatocyte Growth Factor as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Hepatocyte Growth Factor Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Hepatocyte Growth Factor Sales by Region (2020-2025) & (K Units)
Table 18. Global Hepatocyte Growth Factor Sales Market Share by Region (2020-2025)
Table 19. Global Hepatocyte Growth Factor Sales by Region (2026-2031) & (K Units)
Table 20. Global Hepatocyte Growth Factor Sales Market Share by Region (2026-2031)
Table 21. Global Hepatocyte Growth Factor Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Hepatocyte Growth Factor Revenue Market Share by Region (2020-2025)
Table 23. Global Hepatocyte Growth Factor Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Hepatocyte Growth Factor Revenue Market Share by Region (2026-2031)
Table 25. North America Hepatocyte Growth Factor Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Hepatocyte Growth Factor Sales by Country (2020-2025) & (K Units)
Table 27. North America Hepatocyte Growth Factor Sales by Country (2026-2031) & (K Units)
Table 28. North America Hepatocyte Growth Factor Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Hepatocyte Growth Factor Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Hepatocyte Growth Factor Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Hepatocyte Growth Factor Sales by Country (2020-2025) & (K Units)
Table 32. Europe Hepatocyte Growth Factor Sales by Country (2026-2031) & (K Units)
Table 33. Europe Hepatocyte Growth Factor Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Hepatocyte Growth Factor Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Hepatocyte Growth Factor Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Hepatocyte Growth Factor Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Hepatocyte Growth Factor Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Hepatocyte Growth Factor Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Hepatocyte Growth Factor Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Hepatocyte Growth Factor Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Hepatocyte Growth Factor Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Hepatocyte Growth Factor Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Hepatocyte Growth Factor Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Hepatocyte Growth Factor Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Hepatocyte Growth Factor Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Hepatocyte Growth Factor Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Hepatocyte Growth Factor Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Hepatocyte Growth Factor Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Hepatocyte Growth Factor Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Hepatocyte Growth Factor Sales (K Units) by Type (2020-2025)
Table 51. Global Hepatocyte Growth Factor Sales (K Units) by Type (2026-2031)
Table 52. Global Hepatocyte Growth Factor Sales Market Share by Type (2020-2025)
Table 53. Global Hepatocyte Growth Factor Sales Market Share by Type (2026-2031)
Table 54. Global Hepatocyte Growth Factor Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Hepatocyte Growth Factor Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Hepatocyte Growth Factor Revenue Market Share by Type (2020-2025)
Table 57. Global Hepatocyte Growth Factor Revenue Market Share by Type (2026-2031)
Table 58. Global Hepatocyte Growth Factor Price (USD/Unit) by Type (2020-2025)
Table 59. Global Hepatocyte Growth Factor Price (USD/Unit) by Type (2026-2031)
Table 60. Global Hepatocyte Growth Factor Sales (K Units) by Application (2020-2025)
Table 61. Global Hepatocyte Growth Factor Sales (K Units) by Application (2026-2031)
Table 62. Global Hepatocyte Growth Factor Sales Market Share by Application (2020-2025)
Table 63. Global Hepatocyte Growth Factor Sales Market Share by Application (2026-2031)
Table 64. Global Hepatocyte Growth Factor Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Hepatocyte Growth Factor Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Hepatocyte Growth Factor Revenue Market Share by Application (2020-2025)
Table 67. Global Hepatocyte Growth Factor Revenue Market Share by Application (2026-2031)
Table 68. Global Hepatocyte Growth Factor Price (USD/Unit) by Application (2020-2025)
Table 69. Global Hepatocyte Growth Factor Price (USD/Unit) by Application (2026-2031)
Table 70. Helixsmith Company Information
Table 71. Helixsmith Description and Business Overview
Table 72. Helixsmith Hepatocyte Growth Factor Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 73. Helixsmith Hepatocyte Growth Factor Product
Table 74. Helixsmith Recent Developments/Updates
Table 75. Exelixis Company Information
Table 76. Exelixis Description and Business Overview
Table 77. Exelixis Hepatocyte Growth Factor Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. Exelixis Hepatocyte Growth Factor Product
Table 79. Exelixis Recent Developments/Updates
Table 80. AnGes MG Company Information
Table 81. AnGes MG Description and Business Overview
Table 82. AnGes MG Hepatocyte Growth Factor Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. AnGes MG Hepatocyte Growth Factor Product
Table 84. AnGes MG Recent Developments/Updates
Table 85. Athira Pharma Company Information
Table 86. Athira Pharma Description and Business Overview
Table 87. Athira Pharma Hepatocyte Growth Factor Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Athira Pharma Hepatocyte Growth Factor Product
Table 89. Athira Pharma Recent Developments/Updates
Table 90. AVEO Pharmaceuticals Company Information
Table 91. AVEO Pharmaceuticals Description and Business Overview
Table 92. AVEO Pharmaceuticals Hepatocyte Growth Factor Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. AVEO Pharmaceuticals Hepatocyte Growth Factor Product
Table 94. AVEO Pharmaceuticals Recent Developments/Updates
Table 95. Molecular Partners Company Information
Table 96. Molecular Partners Description and Business Overview
Table 97. Molecular Partners Hepatocyte Growth Factor Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Molecular Partners Hepatocyte Growth Factor Product
Table 99. Molecular Partners Recent Developments/Updates
Table 100. Kringle Pharma Company Information
Table 101. Kringle Pharma Description and Business Overview
Table 102. Kringle Pharma Hepatocyte Growth Factor Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Kringle Pharma Hepatocyte Growth Factor Product
Table 104. Kringle Pharma Recent Developments/Updates
Table 105. Beijing Northland Company Information
Table 106. Beijing Northland Description and Business Overview
Table 107. Beijing Northland Hepatocyte Growth Factor Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Beijing Northland Hepatocyte Growth Factor Product
Table 109. Beijing Northland Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Hepatocyte Growth Factor Distributors List
Table 113. Hepatocyte Growth Factor Customers List
Table 114. Hepatocyte Growth Factor Market Trends
Table 115. Hepatocyte Growth Factor Market Drivers
Table 116. Hepatocyte Growth Factor Market Challenges
Table 117. Hepatocyte Growth Factor Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
Table 121. Authors List of This Report
List of Figures
Figure 1. Product Picture of Hepatocyte Growth Factor
Figure 2. Global Hepatocyte Growth Factor Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Hepatocyte Growth Factor Market Share by Type: 2024 & 2031
Figure 4. Phase III (Ongoing) Product Picture
Figure 5. Phase II (Approved) Product Picture
Figure 6. Phase II (Ongoing) Product Picture
Figure 7. Phase 1 Product Picture
Figure 8. Preclinical Product Picture
Figure 9. Approved / Marketed Product Picture
Figure 10. Global Hepatocyte Growth Factor Market Value by Application (2020-2031) & (US$ Million)
Figure 11. Global Hepatocyte Growth Factor Market Share by Application: 2024 & 2031
Figure 12. Oncology
Figure 13. Cardiovascular
Figure 14. Central Nervous System
Figure 15. Hematological Disorders
Figure 16. Others
Figure 17. Global Hepatocyte Growth Factor Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global Hepatocyte Growth Factor Market Size (2020-2031) & (US$ Million)
Figure 19. Global Hepatocyte Growth Factor Sales (2020-2031) & (K Units)
Figure 20. Global Hepatocyte Growth Factor Average Price (USD/Unit) & (2020-2031)
Figure 21. Hepatocyte Growth Factor Report Years Considered
Figure 22. Hepatocyte Growth Factor Sales Share by Manufacturers in 2024
Figure 23. Global Hepatocyte Growth Factor Revenue Share by Manufacturers in 2024
Figure 24. Global 5 and 10 Largest Hepatocyte Growth Factor Players: Market Share by Revenue in Hepatocyte Growth Factor in 2024
Figure 25. Hepatocyte Growth Factor Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 26. Global Hepatocyte Growth Factor Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 27. North America Hepatocyte Growth Factor Sales Market Share by Country (2020-2031)
Figure 28. North America Hepatocyte Growth Factor Revenue Market Share by Country (2020-2031)
Figure 29. U.S. Hepatocyte Growth Factor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Canada Hepatocyte Growth Factor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Europe Hepatocyte Growth Factor Sales Market Share by Country (2020-2031)
Figure 32. Europe Hepatocyte Growth Factor Revenue Market Share by Country (2020-2031)
Figure 33. Germany Hepatocyte Growth Factor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. France Hepatocyte Growth Factor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. U.K. Hepatocyte Growth Factor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Italy Hepatocyte Growth Factor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Russia Hepatocyte Growth Factor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Asia Pacific Hepatocyte Growth Factor Sales Market Share by Region (2020-2031)
Figure 39. Asia Pacific Hepatocyte Growth Factor Revenue Market Share by Region (2020-2031)
Figure 40. China Hepatocyte Growth Factor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Japan Hepatocyte Growth Factor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. South Korea Hepatocyte Growth Factor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. India Hepatocyte Growth Factor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Australia Hepatocyte Growth Factor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Taiwan Hepatocyte Growth Factor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Indonesia Hepatocyte Growth Factor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Thailand Hepatocyte Growth Factor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Malaysia Hepatocyte Growth Factor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Philippines Hepatocyte Growth Factor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Latin America Hepatocyte Growth Factor Sales Market Share by Country (2020-2031)
Figure 51. Latin America Hepatocyte Growth Factor Revenue Market Share by Country (2020-2031)
Figure 52. Mexico Hepatocyte Growth Factor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Brazil Hepatocyte Growth Factor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Argentina Hepatocyte Growth Factor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Middle East and Africa Hepatocyte Growth Factor Sales Market Share by Country (2020-2031)
Figure 56. Middle East and Africa Hepatocyte Growth Factor Revenue Market Share by Country (2020-2031)
Figure 57. Turkey Hepatocyte Growth Factor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 58. Saudi Arabia Hepatocyte Growth Factor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 59. U.A.E Hepatocyte Growth Factor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 60. Global Sales Market Share of Hepatocyte Growth Factor by Type (2020-2031)
Figure 61. Global Revenue Market Share of Hepatocyte Growth Factor by Type (2020-2031)
Figure 62. Global Hepatocyte Growth Factor Price (USD/Unit) by Type (2020-2031)
Figure 63. Global Sales Market Share of Hepatocyte Growth Factor by Application (2020-2031)
Figure 64. Global Revenue Market Share of Hepatocyte Growth Factor by Application (2020-2031)
Figure 65. Global Hepatocyte Growth Factor Price (USD/Unit) by Application (2020-2031)
Figure 66. Hepatocyte Growth Factor Value Chain
Figure 67. Channels of Distribution (Direct Vs Distribution)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Hepatocyte Growth Factor market?
The top companies in the global Hepatocyte Growth Factor market are Helixsmith、Exelixis、AnGes MG.
What is the annual compound growth rate of the global Hepatocyte Growth Factor market size from 2025 to 2031?
What was the global market size of Hepatocyte Growth Factor in 2025?
What was the global market size of Hepatocyte Growth Factor in 2031?
Which region is expected to have the highest market share?
Related Reports
Global Hepatocyte Growth Factor Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Hepatocyte Growth Factor market size was US$ 97 million in 2025 and is forecast to reach a readjusted size of US$ 534 million by 2032 with a CAGR of 28.0% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 77
USD 4250.00
(Single User License)
Global Hepatocyte Growth Factor Market Research Report 2026
The global Hepatocyte Growth Factor market was valued at US$ 97 million in 2025 and is anticipated to reach US$ 534 million by 2032, at a CAGR of 28.0% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 109
USD 2900.00
(Single User License)
Hepatocyte Growth Factor- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Hepatocyte Growth Factor was estimated to be worth US$ 97 million in 2025 and is projected to reach US$ 534 million, growing at a CAGR of 28.0% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 93
USD 3950.00
(Single User License)
Hepatocyte Growth Factor - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Hepatocyte Growth Factor was estimated to be worth US$ 75.8 million in 2024 and is forecast to a readjusted size of US$ 426 million by 2031 with a CAGR of 28.0% during the forecast period 2025-2031.
Published Date: 2025-10-21
Pages: 105
USD 3950.00
(Single User License)
Global Hepatocyte Growth Factor Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Hepatocyte Growth Factor market is projected to grow from US$ 75.8 million in 2024 to US$ 426 million by 2031, at a CAGR of 28.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 143
USD 4900.00
(Single User License)
Global Hepatocyte Growth Factor Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Hepatocyte Growth Factor market size was US$ 75.8 million in 2024 and is forecast to a readjusted size of US$ 426 million by 2031 with a CAGR of 28.0% during the forecast period 2025-2031.
Published Date: 2025-08-13
Pages: 80
USD 4250.00
(Single User License)
Global Hepatocyte Growth Factor Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Hepatocyte Growth Factor was estimated to be worth US$ 75.8 million and is forecast to reach approximately US$ 464 million by 2031 with a CAGR of 30.0% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 140
USD 5900.00
(Single User License)
Hepatocyte Growth Factor- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Hepatocyte Growth Factor was estimated to be worth US$ 75.8 million in 2024 and is forecast to a readjusted size of US$ 464 million by 2031 with a CAGR of 30.0% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 98
USD 3950.00
(Single User License)
Global Hepatocyte Growth Factor Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Hepatocyte growth factor (HGF) (or scatter factor (SF) is a paracrine cellular growth, motility and morphogenic factor. It is secreted by mesenchymal cells and targets and acts primarily upon epithelial cells and endothelial cells, but also acts on haemopoietic progenitor cells and T cells. It has been shown to have a major role in embryonic organ development, specifically in myogenesis, in adult organ regeneration, and in wound healing.
Published Date: 2024-04-17
Pages: 138
USD 5600.00
(Single User License)
Global Hepatocyte Growth Factor Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Hepatocyte growth factor (HGF) (or scatter factor (SF) is a paracrine cellular growth, motility and morphogenic factor. It is secreted by mesenchymal cells and targets and acts primarily upon epithelial cells and endothelial cells, but also acts on haemopoietic progenitor cells and T cells. It has been shown to have a major role in embryonic organ development, specifically in myogenesis, in adult organ regeneration, and in wound healing.
Published Date: 2024-04-16
Pages: 128
USD 5900.00
(Single User License)
Global Hepatocyte Growth Factor Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Hepatocyte Growth Factor market size was US$ 97 million in 2025 and is forecast to reach a readjusted size of US$ 534 million by 2032 with a CAGR of 28.0% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 77
USD 4250.00 (Single User License)Global Hepatocyte Growth Factor Market Research Report 2026
The global Hepatocyte Growth Factor market was valued at US$ 97 million in 2025 and is anticipated to reach US$ 534 million by 2032, at a CAGR of 28.0% from 2026 to 2032.
Published: 2026-01-04
Pages: 109
USD 2900.00 (Single User License)Hepatocyte Growth Factor- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Hepatocyte Growth Factor was estimated to be worth US$ 97 million in 2025 and is projected to reach US$ 534 million, growing at a CAGR of 28.0% from 2026 to 2032.
Published: 2026-01-04
Pages: 93
USD 3950.00 (Single User License)Hepatocyte Growth Factor - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Hepatocyte Growth Factor was estimated to be worth US$ 75.8 million in 2024 and is forecast to a readjusted size of US$ 426 million by 2031 with a CAGR of 28.0% during the forecast period 2025-2031.
Published: 2025-10-21
Pages: 105
USD 3950.00 (Single User License)Global Hepatocyte Growth Factor Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Hepatocyte Growth Factor market is projected to grow from US$ 75.8 million in 2024 to US$ 426 million by 2031, at a CAGR of 28.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 143
USD 4900.00 (Single User License)Global Hepatocyte Growth Factor Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Hepatocyte Growth Factor market size was US$ 75.8 million in 2024 and is forecast to a readjusted size of US$ 426 million by 2031 with a CAGR of 28.0% during the forecast period 2025-2031.
Published: 2025-08-13
Pages: 80
USD 4250.00 (Single User License)Global Hepatocyte Growth Factor Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Hepatocyte Growth Factor was estimated to be worth US$ 75.8 million and is forecast to reach approximately US$ 464 million by 2031 with a CAGR of 30.0% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 140
USD 5900.00 (Single User License)Hepatocyte Growth Factor- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Hepatocyte Growth Factor was estimated to be worth US$ 75.8 million in 2024 and is forecast to a readjusted size of US$ 464 million by 2031 with a CAGR of 30.0% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 98
USD 3950.00 (Single User License)Global Hepatocyte Growth Factor Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Hepatocyte growth factor (HGF) (or scatter factor (SF) is a paracrine cellular growth, motility and morphogenic factor. It is secreted by mesenchymal cells and targets and acts primarily upon epithelial cells and endothelial cells, but also acts on haemopoietic progenitor cells and T cells. It has been shown to have a major role in embryonic organ development, specifically in myogenesis, in adult organ regeneration, and in wound healing.
Published: 2024-04-17
Pages: 138
USD 5600.00 (Single User License)Global Hepatocyte Growth Factor Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Hepatocyte growth factor (HGF) (or scatter factor (SF) is a paracrine cellular growth, motility and morphogenic factor. It is secreted by mesenchymal cells and targets and acts primarily upon epithelial cells and endothelial cells, but also acts on haemopoietic progenitor cells and T cells. It has been shown to have a major role in embryonic organ development, specifically in myogenesis, in adult organ regeneration, and in wound healing.
Published: 2024-04-16
Pages: 128
USD 5900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 2900.00
USD 4350.00
USD 5800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
REPORT SCOPE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now